Navigation Links
Advia 1650 Chemistry System

ProductsAdvia 1650 Chemistry System
Company Siemens Medical Solutions Diagnostics
Item Advia 1650 Chemistry System
Features 
  • Microvolume sample technology
    Minimal sample volume requirements provide sample management efficiency.
  • Microvolume reagent technology
    Maximizes on-board capacity and reduces operator interventions.
  • Automation-ready sample probe
    Swings 180 away from system to provide direct-track sampling with the ADVIA WorkCell or ADVIA LabCell Modular Automation System.
  • Open-system capability
    100 channels, 62 available for user-defined applications.
  • Innovative optical system
    Elongated cuvette path length and fluorocarbon oil incubation bath maximize result accuracy while using microvolume technology for samples and reagents.
  • ADVIA 1650 Universal Rack Handler
    Automatic rack loading and unloading system ensures unprecedented testing convenience and flexibility. Universal sample racks and carrying trays also retrofit to ADVIA Centaur system.
Description Microvolume technology
The ADVIA 1650 has minimal requirements for sample volume (as low as 2 L/test), reagent consumption (as low as 80 L/test) and water consumption (25 L/hour) - thus maximizing management efficiency.

Outstanding productivity
A rapid, 3-second cycle and system throughput of up to 1650 tests/hour provide powerful high-speed performance, ensure workflow efficiency through peak workloads. Optional universal rack handler facilitates continuous sample feeding for further productivity gains.

Unparalleled walkaway capability
On-board capacity of 200 samples and 32,000 tests - plus our exclusive Sample Saver Technology for automatic repeat, dilution and reflex testing without operator intervention - optimizes walkaway time, frees you to work on additional tasks.

Expertise in automation
For 50 years we have been recognized for our innovation - just as clinical chemistry has been recognized as the driver of automation. The tradition continues. The ADVIA 1650 can be integrated with other testing disciplines via the ADVIA WorkCell or ADVIA LabCell automated sample transportation systems.

Info Siemens Medical Solutions Diagnostics
Customer Service: 800-255-3232 or 914-631-8000
Web site: http://www.siemens.com/diagnostics-products

Related medicine products :

1. Advia 60
2. Advia 70
3. Advia 120
4. Advia 2400 Chemistry System
5. Advia WorkCell CDX Modular Automation
6. Advia Centaur
7. Advia 1650
8. Advia 2400
9. Advia S60 Autoslide System
10. Advia 1200 Chemistry System
11. Aeroset Clinical Chemistry System
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products:
(Date:7/18/2008)... 18 /PRNewswire/ -- minSURG Corporation,producers...n procedure,announced today the creation of minSU...division has been established in response to globa... CEO, Jim Doulgeris said, "Distributors from Canad...ds, Singapore, Taiwan, Turkey and Japan have,expre...
(Date:7/18/2008)...ch into the earliest events occurring immediately ...ls a stunning blow to the immune system earlier th...sts at Duke University Medical Center, this sugges...ention may be only a matter of days not weeks af...lieved. , Appearing in the August issue of the ...
(Date:7/18/2008).../PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC,Bul... in the development,and commercialization of anti-...l implants, announced today the appointment of Ms....irector, International Market Development.,Ms. Mun...years of sales,sales management and market develo...
(Date:7/18/2008)...Leading long-term care software companies offer se...ons systems. , Indianapol...veloper of Clinical Management Software for the lo...s, a national provider of patient referral softwar...rtnership to help long term care facilities effici...
Breaking Medicine News(10 mins):Health News:minSURG(TM) Corporation Launches International Division 2Health News:HIV conquers immune system faster than previously realized 2Health News:HIV conquers immune system faster than previously realized 3Health News:SyntheMed Appoints Corinne Mundin as Director, International Market Development 2Health News:SyntheMed Appoints Corinne Mundin as Director, International Market Development 3Health News:Qtrac Software and Patient Placement Systems Announce Partnership and Healthcare Data Interface 2Health News:Qtrac Software and Patient Placement Systems Announce Partnership and Healthcare Data Interface 3
...delaying pregnancy may result in shortened life ex...men deciding to put off pregnancy for the sake of ...r women across the globe. Delaying in getting preg...ffspring, like abnormal number of chromosomes, and...
...arcotics for chronic pain in elderly works, as the.... On the other hand, the use of the drug for young...age with serious health repercussions. The drugs i...ns like morphine, methadone and oxycodone. Opioid ...
...sible to use the human cells immune process to act...he first time scientists feel that it may be possi...n a novel HIV therapy. The process is called RNA s...in plants and animals, only it was not known for h...
...ntist of Vanderbilt University have developed a ne...to neural circuits that play a role in development...at make us apply previously learned rules on new s...he researchers feel that the new use of technology...
Other Medicine News:
(Date:7/16/2008)...KAISER FAMILY FOUNDATION PARTNER TO,OFFER DAILY, C...LO PARK, Calif., and GENEVA, July 16 /PRNewswire-U... and the Kaiser Family Foundation will,provide wor...S Conference,(AIDS 2008) taking place in Mexico Ci...ent operating foundation based in Menlo Park, Cali...
(Date:7/16/2008)...ivotal Phase 2b Clinical Trials of First, Potent...ic Fibrosis -, SOUTH PLAINFIELD, N.J. and BETHESD...Inc. (PTC) and Cystic Fibrosis Foundation Therapeu...Cystic Fibrosis Foundation, today,announced the ex...velopment,of PTC124, the PTC,s new investigational...
(Date:7/15/2008)...ble Phase 1 RX-3341 Results -, NEW HAVEN, Conn., ....,("Rib-X" or the "Company"), a development-stage ...f novel antibiotics for the treatment of,antibioti...tion of a Phase,2 clinical trial for an intravenou...ment of complicated skin and skin structure infect...
(Date:7/15/2008)...Scimitar Equity, LLC issues a review of,Advaxis, I...Generation of,Cancer Immunotherapeutics"., This r...requity.com ., Based in North Brunswick, New Jers...a monocytogenes ("Lm") cancer vaccines based on,te...or of Microbiology at,the University of Pennsylvan...
Breaking Medicine Technology:Online Coverage of International AIDS Conference Includes Daily Webcasts, Podcasts and Interviews 2Online Coverage of International AIDS Conference Includes Daily Webcasts, Podcasts and Interviews 3Online Coverage of International AIDS Conference Includes Daily Webcasts, Podcasts and Interviews 4PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 2PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 3PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 4Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections 2Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections 3Advaxis, Inc Initiation Coverage Review Issued By Scimitar Equity, LLC 2Biomarkers allow doctors to match therapy to patient 2869 1Biomarkers allow doctors to match therapy to patient 2869 2Biomarkers allow doctors to match therapy to patient 2869 3Biomarkers allow doctors to match therapy to patient 2869 4Biomarkers allow doctors to match therapy to patient 2869 5Biomarkers allow doctors to match therapy to patient 2869 6Biomarkers allow doctors to match therapy to patient 2869 7A genetic cause for iron deficiency 2866 1A genetic cause for iron deficiency 2866 2Penn researchers find targeted therapy combination overcomes treatment resistance in liver cancer 16643 1Penn researchers find targeted therapy combination overcomes treatment resistance in liver cancer 16643 2Agrenco Informs Sale of Biodiesel at ANP Auction 4558 1
...Array BioPharma Inc.,(Nasdaq: ARRY) today announce...ay, will speak at the C.E Unterbeg, Towbin Emergin...he public is,welcome to participate in the confere...te. -0-, ,Event: C.E Unterbeg, Towbin Eme... Conway, Chief Executive Officer, Array, ...
... - GTC,Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB)...hairman and CEO, is scheduled to,present on Wednes...terberg, Towbin Emerging Growth Life Opportunities...andarin Oriental Hotel, New,York, New York from Ju...t live and can be accessed by,logging onto www.gtc...
Other Medicine Technology:GTC Biotherapeutics to Webcast Corporate Presentation at the C.E.,Unterberg, Towbin Emerging Growth Life Opportunities Conference 2